Association between Sarcopenic Obesity and Bone Mineral Density in Middle-Aged and Elderly Korean
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Objectives: To identify the prevalence of osteosarcopenic obesity and to evaluate the association between sarcopenic obesity and bone mineral density in middle-aged and elderly Korean. Methods: This study included 3,385 males and 4,064 females (age ≥50 years and in the stage of menopause) who participated in the Korean National Health and Nutrition Examination Survey (KNHANES) from 2008 to 2011. The cutoff value for sarcopenia was 7.26 kg/m 2 for men and 5.45 kg/m 2 for female. The fat mass was >30% for men and 40% for female; these values were used to define obesity. Based on the combination of sarcopenia and obesity status, all subjects were classified as sarcopenic obese (SO), sarcopenic nonobese (SNO), nonsarcopenic obese (NSO), or nonsarcopenic nonobese. Results: The incidence rates of sarcopenia, sarcopenic obesity, and osteosarcopenic obesity were 31.5, 5.1, and 4.1%, respectively. Following adjustment, the ORs for osteoporosis were 8.67 in the SO group (95% CI 4.19-17.94), 3.85 in the SNO group (95% CI 2.61-5.67), and 1.88 in the NSO group (95% CI 0.72-4.91) in men and 2.93 in the SO group (95% CI 1.99-4.32), 1.71 in the SNO group (95% CI 1.31-2.23), and 0.58 in the NSO group (95% CI 0.43-0.78) in women. Conclusions: Sarcopenic obesity is associated with the development of osteoporosis among the middle-aged and elderly Korean population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The risk of osteoporosis was higher in the sarcopenic obesity group (based on ALM/ht2 and % body fat) (OR: 8.67, 95% CI: 4.19–17.94 in men and OR: 2.93, 95% CI: 1.99–4.32 in women) (115).”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [115]
In the citing paper
“Sarcopenic obesity was associated with increased odds for the development of osteoporosis among the middle-aged and older-aged Korean population [25].”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [25]
In the citing paper
“However, without a standardised definition of osteosarcopenic obesity it is difficult to make comparisons and draw conclusions on prevalence of as the published studies use multiple definitions for the osteosarcopenic obesity components (Table 1) [24][25][26].”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [25]
In the citing paper
“A prevalence of 12-19% of osteosarcopenic obesity has been reported in women aged over 50 years [24][25][26].”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [25]
In the citing paper
“Investigation of the Korean National Health and Nutrition Examination Survey (including N = 3385 men and N = 4064 women aged > 50 years) found the incidence of sarcopenia, sarcopenic obesity, and osteosarcopenic obesity as 31.5%,5.1%, and 4.1%, respectively.”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [25]
Citations
Cites
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004
Kanis, J. A., & Kanis, J. A. (1994) · Osteoporosis International · doi:10.1007/bf01622200 · Cited by 2,516
Bliuc, D. (2009) · JAMA · doi:10.1001/jama.2009.50 · Cited by 1,699
Epidemiology, etiology, and diagnosis of osteoporosis
Lane, N. E. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.08.047 · Cited by 1,293
Matkovic, V, Jelic, T., Wardlaw, G. M., Ilich, J. Z., Goel, P. K., Wright, J. K., Andon, M. B., Smith, K. T., & Heaney, R. P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117034 · Cited by 806
Sarcopenic obesity: a critical appraisal of the current evidence
Prado, C. M. M., Wells, J. C. K., Smith, S. R., Stephan, B. C. M., & Siervo, M. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.06.010 · Cited by 589
Layman, D. K., Boileau, R. A., Erickson, D. J., Painter, J. E., Shiue, H., Sather, C., & Christou, D. D. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.2.411 · Cited by 541
Sarcopenic Obesity: The Confluence of Two Epidemics
Roubenoff, R. (2004) · Obesity Research · doi:10.1038/oby.2004.107 · Cited by 453
Cited by
Kalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882
Sarcopenic obesity in older adults: a clinical overview
Prado, C. M., Batsis, J. A., Donini, L. M., Gonzalez, M. C., & Siervo, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00943-z · Cited by 355
“…35,43 , functional limitation 35 , risk of falls 25,35 , depressive symptoms 28,39 , dementia 43 , prefrailty and frailty 29,45 , osteoporosis 23 , short sleep duration 24 , low physical activity level 24 , fatigue 24 and disability 40 ), effects on cancer outcomes and treatment (decreased…”
Donini, L. M., Busetto, L., Bauer, J. M., Bischoff, S., Boirie, Y., Cederholm, T., Cruz-Jentoft, A. J., Dicker, D., Frühbeck, G., Giustina, A., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.11.024 · Cited by 326
Aging human body: changes in bone, muscle and body fat with consequent changes in nutrient intake
JafariNasabian, P., Inglis, J. E., Reilly, W., Kelly, O. J., & Ilich, J. Z. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0603 · Cited by 310
“2015, Chung et al. 2016).”
BackgroundHealth Consequences of Sarcopenic Obesity: A Narrative Review
Roh, E., & Choi, K. M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00332 · Cited by 304
Scott, D., Seibel, M., Cumming, R., Naganathan, V., Blyth, F., Le Couteur, D. G., Handelsman, D. J., Waite, L. M., & Hirani, V. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3016 · Cited by 174
“In cross-sectional studies, Korean older men with both sarcopenia and obesity (“sarcopenic obesity”) had eightfold higher likelihood for osteoporosis compared with those without sarcopenia or obesity,((5)) and sarcopenic obese older Australians attending a falls clinic had significantly lower hip bone mineral density…”
BackgroundSarcopenia and Its Implications for Metabolic Health
Hunter, G. R., Singh, H., Carter, S. J., Bryan, D. R., & Fisher, G. (2019) · Journal of Obesity · doi:10.1155/2019/8031705 · Cited by 153
“Importantly, this relationship remains after adjusting for age, sex, and exercise level [82].”
BackgroundWeight‐adjusted waist as an integrated index for fat, muscle and bone health in adults
Kim, K. J., Son, S., Kim, K. J., Kim, S. G., & Kim, N. H. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13302 · Cited by 154
Chronic stress and body composition disorders: implications for health and disease
Stefanaki, C., Pervanidou, P., Boschiero, D., & Chrousos, G. P. (2018) · HORMONES · doi:10.1007/s42000-018-0023-7 · Cited by 183
Gandham, A., Mesinovic, J., Jansons, P., Zengin, A., Bonham, M. P., Ebeling, P. R., & Scott, D. (2021) · Obesity Reviews · doi:10.1111/obr.13187 · Cited by 128
“However, a leave-one-out sensitivity analysis (Figure S2) demonstrated that exclusion of the Chung et al.(23) study, which was given the highest weight (32% to 62%) in this meta-analysis, resulted in a lack of significant mean difference in femoral neck aBMD between individuals with sarcopenic obesity and controls.”
ResultOsteosarcopenic Obesity: Current Knowledge, Revised Identification Criteria and Treatment Principles
Kelly, O. J., Gilman, J. C., Boschiero, D., & Ilich, J. Z. (2019) · Nutrients · doi:10.3390/nu11040747 · Cited by 126
“A study in Korean middle aged and elderly males and females, 50 years or older, found that sarcopenic obesity was strongly associated with osteoporosis [30].”
Sarcopenia as a comorbidity of cardiovascular disease
Sasaki, K., & Fukumoto, Y. (2021) · Journal of Cardiology · doi:10.1016/j.jjcc.2021.10.013 · Cited by 128
Szlejf, C., Parra-Rodríguez, L., & Rosas-Carrasco, O. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.02.023 · Cited by 104
Bauer, J. M., Cruz-Jentoft, A. J., Fielding, R. A., Kanis, J. A., Reginster, J.-Y., Bruyère, O., Cesari, M., Chapurlat, R., Al-Daghri, N., Dennison, E., et al. (2019) · Calcified Tissue International · doi:10.1007/s00223-019-00561-w · Cited by 83
Perna, S., Spadaccini, D., Nichetti, M., Avanzato, I., Faliva, M. A., & Rondanelli, M. (2018) · Journal of Aging Research · doi:10.1155/2018/6147426 · Cited by 65
“In addition, OSO is a common condition in middle-aged and older women, and it is independently associated with frailty and poor physical performance [6].”
BackgroundEffects of progressive elastic band resistance exercise for aged osteosarcopenic adiposity women
Lee, Y.-H., Lee, P.-H., Lin, L.-F., Liao, C.-D., Liou, T.-H., & Huang, S.-W. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111272 · Cited by 62
Van Aller, C., Lara, J., Stephan, B. C. M., Donini, L. M., Heymsfield, S., Katzmarzyk, P. T., Wells, J. C. K., Prado, C. M., & Siervo, M. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.01.022 · Cited by 56
Potential Functions of the BMP Family in Bone, Obesity, and Glucose Metabolism
Chen, Y., Ma, B., Wang, X., Zha, X., Sheng, C., Yang, P., & Qu, S. (2021) · Journal of Diabetes Research · doi:10.1155/2021/6707464 · Cited by 85
Peppa, Μ., Stefanaki, C., Papaefstathiou, A., Boschiero, D., Dimitriadis, G., & Chrousos, G. P. (2017) · HORMONES · doi:10.14310/horm.2002.1732 · Cited by 61
Yang, L., Wu, G.-H., Yang, Y.-L., Wu, Y., Zhang, L., Wang, M., Mo, L., Xue, G., Wang, C., & Weng, X. (2019) · Medical Science Monitor · doi:10.12659/msm.914031 · Cited by 57
Kim, Y. M., Kim, S., Won, Y. J., & Kim, S. H. (2019) · Calcified Tissue International · doi:10.1007/s00223-019-00551-y · Cited by 43
“Moreover, it is still unclear whether the loss of bone and muscle masses in obese state influences each other to develop OSO syndrome among elderly [3, 8].”
Associations of components of sarcopenic obesity with bone health and balance in older adults
Scott, D., Shore-Lorenti, C., McMillan, L., Mesinovic, J., Clark, R. A., Hayes, A., Sanders, K. M., Duque, G., & Ebeling, P. R. (2018) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2017.12.006 · Cited by 38
Chen, X., Kong, C., Yu, H., Gong, J., Lan, L., Zhou, L., Gong, J., Liu, P., Xu, L., & Deng, Q. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026818 · Cited by 42
“In the female population, 3.51% of the Hmong participants, 3.15% of the Maonan participants, 1.71% of the Jing participants and 0.37% of the Yao participants had OSO.”
BackgroundInfluentialLow muscle mass is associated with osteoporosis: A nationwide population-based study
Jang, S.-Y., Park, J., Ryu, S. Y., & Choi, S.-W. (2020) · Maturitas · doi:10.1016/j.maturitas.2020.01.003 · Cited by 44
Physical Performance Variables and Bone Mineral Density in a Group of Young Overweight and Obese Men
Khoury, C. E., Pinti, A., Lespessailles, É., Maalouf, G., Watelain, É., Khoury, G. E., Berro, A.-J., Ayoub, M.-L., Toumi, H., & Hage, R. E. (2016) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2016.07.004 · Cited by 41
Muscle mass measures and incident osteoporosis in a large cohort of postmenopausal women
Papageorgiou, M., Sathyapalan, T., & Schutte, R. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12359 · Cited by 38
Blümel, J. E., Arteaga, E., Aedo, S., Arriola‐Montenegro, J., López, M., Martino, M., Miranda, C., Miranda, O., Mostajo, D., Ñañez, M., et al. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1718092 · Cited by 35
Liu, Y., Song, Y., Hao, Q., & Wu, J. (2023) · Archives of Osteoporosis · doi:10.1007/s11657-023-01247-5 · Cited by 39
Chen, Y., Fang, W., Wang, C., Kao, T., Chang, Y., Wu, C., Zhou, Y., Sun, Y., & Chen, W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206812 · Cited by 34
Dysmobility syndrome: current perspectives
Hill, K., Farrier, K., Russell, M. A., & Burton, E. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s102961 · Cited by 34
Sarcopenic obesity and osteoporosis: Research progress and hot spots
Fan, S., Cai, Y., Wei, Y., Yang, J., Gao, J., & Yang, Y. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112544 · Cited by 33
“A Korean study of middle-aged people in menopause indicated that SO is related to the development of osteoporosis in the middle-aged and elderly Korean population (Chung et al., 2016).”
Luo, X., Cai, B., & Jin, W. (2022) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2022.0035 · Cited by 29
“…decreasing physical activity, skeletal muscle mass undergoes a progressive decline accompanied by loss of muscle strength and bone mineral density, 42 and at the same time, the loss of mass of skeletal muscle, one of the main target organs for insulin, may cause insulin resistance, which leads to…”
Bone Variables in Active Overweight/Obese Men and Sedentary Overweight/Obese Men
Khoury, G. E., Zouhal, H., Cabagno, G., Khoury, C. E., Rizkallah, M., Maalouf, G., & Hage, R. E. (2016) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2016.10.009 · Cited by 25
Kolbaşı, E. N., & Demirdağ, F. (2020) · Archives of Osteoporosis · doi:10.1007/s11657-020-00829-x · Cited by 25
Fruit intake and osteosarcopenic obesity in Korean postmenopausal women aged 50–64 years
Bae, Y. (2020) · Maturitas · doi:10.1016/j.maturitas.2020.02.003 · Cited by 19
Protein intake and osteosarcopenic adiposity in Korean adults aged 50 years and older
Choi, M., & Bae, Y. (2020) · Osteoporosis International · doi:10.1007/s00198-020-05529-3 · Cited by 19
Hernández-Martínez, P., Olmos, J. M., Llorca, J., Hernández, J. L., & González-Macías, J. (2022) · Archives of Osteoporosis · doi:10.1007/s11657-022-01146-1 · Cited by 20
Wood, M. J., Al-Jabri, T., Maniar, A. R., Stelzhammer, T., Lanting, B. A., & Giannoudis, P. V. (2024) · Injury · doi:10.1016/j.injury.2024.111654 · Cited by 17
Chain, A., Faerstein, E., Wahrlich, V., & Bezerra, F. F. (2020) · Nutrition · doi:10.1016/j.nut.2020.110898 · Cited by 18
Lin, Y.-H., & Teng, M. M. (2022) · Archives of Osteoporosis · doi:10.1007/s11657-022-01107-8 · Cited by 15
Vincenzo, O. D., Piciocchi, C., Muzzioli, L., Poggiogalle, E., Frigerio, F., Minnetti, M., Barazzoni, R., Brandi, M. L., Busetto, L., Iolascon, G., et al. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.06.009 · Cited by 19
Chucherd, O., Vallibhakara, O., Vallibhakara, S. A.-O., Sophonsritsuk, A., Chattrakulchai, K., & Anantaburarana, M. (2025) · Archives of Osteoporosis · doi:10.1007/s11657-025-01573-w · Cited by 15
“Similarly, Chung et al. (2016) [26] demonstrated that sarcopenic obesity significantly increased the odds of osteoporosis (OR 2.93) in middle-aged and elderly Korean women.”
InfluentialLiu, Y., Hao, Q., Zhou, J., & Wu, J. (2024) · Osteoporosis International · doi:10.1007/s00198-023-07007-y · Cited by 14
Pal, R., Prasad, T. N., Bhadada, S. K., Singla, V., Yadav, U., & Chawla, N. (2024) · Archives of Osteoporosis · doi:10.1007/s11657-024-01450-y · Cited by 16
“Although available studies suggest that people with sarcopenic obesity are at an increased risk of osteoporosis and fractures compared to those with non-obese sarcopenia [34, 35], we did not find any significant difference either in aBMD, TBS, or HR-pQCT parameters between the two groups.”
Xu, X., Xu, N., Wang, Y., Chen, J., Chen, L., Zhang, S., Chen, J., Deng, H., Luan, X., & Shen, J. (2021) · PeerJ · doi:10.7717/peerj.10753 · Cited by 12
Low bone mineral density in middle-aged women: a red flag for sarcopenia
Campodónico, I., Blümel, J. E., Arteaga, E., Vallejo, M. S., & Valdivia, M. I. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000995 · Cited by 12
Bae, J. H., Seo, J.-W., Li, X., Ahn, S., Sung, Y., & Kim, D. Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-64742-w · Cited by 17
Kashiwagi, K., Takayama, M., Ichikawa, H., Takaishi, H., Iwao, Y., & Kanai∥, T. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.01.045 · Cited by 11
Defining sarcopenia in terms of skeletal health
Kim, J. H., Hong, A. R., Choi, H. J., Ku, E. J., Lee, J., Cho, N. H., & Shin, C. S. (2018) · Archives of Osteoporosis · doi:10.1007/s11657-018-0511-z · Cited by 10
Determination of Cutoff Values for the Screening of Osteosarcopenia in Obese Postmenopausal Women
Abidin, N. Z., & Mitra, S. R. (2021) · Current Gerontology and Geriatrics Research · doi:10.1155/2021/6634474 · Cited by 10
Sarcopenic Obesity: A Comprehensive Approach for Postmenopausal Women
Park, J. Y., Chung, Y., Song, J., Kil, K., Lee, H. Y., Chae, J., & Kim, J.-H. (2024) · Journal of Menopausal Medicine · doi:10.6118/jmm.24004 · Cited by 12
Liu, J., Ji, F., Lee, H., & Kim, J.-H. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112772 · Cited by 8
“Chung et al. (Chung et al., 2016) used the data from the Korea National Health and Nutrition Examination Survey (KNHANES) to examine osteoporosis and sarcopenic obesity in middle-aged and older Korean adults.”
Yu, E. H., Lee, H. J., Kim, H. J., Kim, I. H., Joo, J. K., & Na, Y. J. (2023) · Journal of Menopausal Medicine · doi:10.6118/jmm.23014 · Cited by 11
“A Korean study reported that there was a correlation between an elevated fat mass and insufficient muscle mass, which was associated with the occurrence of osteoporosis and therefore S-O was more closely associated with osteoporosis than any other group [21].”
BackgroundLORENZO, A. D., Itani, L., Gualtieri, P., Pellegrini, M., Ghoch, M. E., & Renzo, L. D. (2023) · Life · doi:10.3390/life14010021 · Cited by 8
“This finding is partially in line with a previous Korean study [37] which found a stronger association between SO and reduced bone mass (i.e., osteoporosis), but they found a lower prevalence of OSO of only 5% against ours of 16%.”
BackgroundMethodResultInfluentialLi, Y., & Xu, Z. (2024) · Geriatric Nursing · doi:10.1016/j.gerinurse.2024.07.001 · Cited by 8
Takayama, M., Azuma, K., Shimizu‐Hirota, R., Makino, K., Seino, T., Yoshida, T., Kashiwagi, K., Hirose, H., Inoue, N., & Iwao, Y. (2018) · Health Evaluation and Promotion · doi:10.7143/jhep.45.573 · Cited by 8
Sarcopenic obesity, pathogenesis, and treatment with a focus on exercise and protein intake
Karaağaç, Y. (2023) · Journal of Mind and Medical Sciences · doi:10.22543/2392-7674.1419 · Cited by 5
“Sarcopenic obesity is associated with a higher risk of diabetes [11], dyslipidemia [11], metabolic syndrome [2], restrictive lung disease [12], osteoporosis [13].”
BackgroundAhmadinezhad, M., Mansournia, M. A., Fahimfar, N., Shafiee, G., Nabipour, I., Sanjari, M., Khalagi, K., Mansourzadeh, M. J., Larijani, B. A., & Ostovar, A. (2023) · Archives of Osteoporosis · doi:10.1007/s11657-023-01340-9 · Cited by 5
“A total of 293 participants in the study had OSO, and the overall prevalence of OSO was 4.2% (3.1% in men and 5.4% in women) [33].”
InfluentialMRI-Based Phenotyping for Osteosarcopenic Adiposity in Subjects from a Population-Based Cohort
Maurer, E., Rospleszcz, S., Rathmann, W., Thorand, B., Peters, A., Schlett, C. L., Bamberg, F., & Kiefer, L. S. (2024) · Geriatrics · doi:10.3390/geriatrics9060150 · Cited by 5
“Reported prevalence rates of OSA range broadly between 0.8 and 40% [35,36].”
InfluentialConstruction of a prediction model for sarcopenic obesity based on machine learning
Xu, M., Liu, J., Hu, S., Luan, T., Duan, Y., Wang, A., Cui, Z., Zhou, J., & Mao, Y. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1576338 · Cited by 7
Sarcopenia in Liver Disease: Current Evidence and Issues to Be sResolved
Song, M., Xia, L., Liu, Q., Sun, M., Wang, F., & Yang, C. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_19 · Cited by 5
Role of microRNAs in Osteosarcopenic Obesity/Adiposity: A Scoping Review
Braile, M., Braile, A., Greggi, C., Visconti, V. V., Toro, G., Trotta, M. C., Conza, G., & Tarantino, U. (2025) · Cells · doi:10.3390/cells14110802 · Cited by 3
Sarcopenic Obesity as a Risk Factor for Cardiovascular Disease: An Underrecognized Clinical Entity
Binu, A. J., Kapoor, N., Bhattacharya, S., Kishor, K., & Kalra, S. (2023) · Heart International · doi:10.17925/hi.2023.17.2.4 · Cited by 4
Metabolic Bone Disease in Geriatric Patients
Gómez, M. P. A., Aparisi, F., Guglielmi, G., & Bazzocchi, A. (2023) · Practical issues in geriatrics · doi:10.1007/978-3-031-14877-4_14 · Cited by 2
Hassan, N. E., Shebini, S. M. E., El-Masry, S. A., Ahmed, N. H., Eldeen, G. N., Rasheed, E. A., Aly, M. M., Alian, K. M., Afify, M. A. S., & Khalil, A. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00127-0 · Cited by 2
Scott, D. S. (2019) · Springer eBooks · doi:10.1007/978-3-030-25890-0_14 · Cited by 2
Ma, Y., Liu, Y., Zhang, S., Cao, L., He, Y., Shuai, X., Liang, H., Chen, F., Gao, J., & Wang, D. (2020) · Research Square · doi:10.21203/rs.3.rs-84790/v1 · Cited by 2
“Second, gender-strati ed analyses were not made in postmenopausal women, characterized by dramatic changes in hormone levels, among whom the high risks of osteoporosis and sarcopenia have always been highlighted [30, 31].”
BackgroundAssessment and Management of Ischaemic Heart Disease in Non-Cardiac Surgery
Morgan, H., Ezad, S. M., Rahman, H., Silva, K. D., Partridge, J. S. L., & Perera, D. (2023) · Heart International · doi:10.17925/hi.2023.17.2.6 · Cited by 4
Obesidade, Diabetes Mellitus tipo 2 e fragilidade óssea: uma revisão narrativa
Gomes, T. P. S., Veloso, F. L. D. M., Filho, J. A., Mourão, F. C., Nascif, N. H. T., Loures, E. D. A., Labronici, P. J., & Mendes, A. F. (2019) · HU Revista · doi:10.34019/1982-8047.2018.v44.14058 · Cited by 1
(2021) · PeerJ · doi:10.7287/peerj.10753v0.1/reviews/3
“Most previous studies used one indicator to define ASM mass, which makes it impossible to compare the data across studies (Chung et al., 2016; Kim et al., 2014).”
ResultIndriani, O. L., Sari, A. D., Putri, M., Putra, S. B. P., Rudy, H., Anna, A., & Kuswardhani, T. (2022) · Journal of Geriatric Medicine and Gerontology · doi:10.23937/2469-5858/1510136
“Based on random effect model, it was known that osteoporosis risk was insignificantly higher in sarcopenic group compared to control group (RR 3.89; 95% CI 0.907-16.729) [ 7 , 14 , 18].”
BackgroundInfluentialKhalil, N., Hage, R. E., Hammoud, E. I., Maliha, E., Khoury, G. E., Hage, Z. E., & Jacob, C. (2026) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2026.101667
Santoso, A. H., Firmansyah, Y., Sari, T., Martin, A., Priyana, A., Wijaya, B. A., Dinali, D., Dzakwan, M. F., Endarti, A. T., Ernawati, et al. (2026) · Obesities · doi:10.3390/obesities6050060
“Both conditions are strongly associated with metabolic and cardiovascular disorders, including diabetes, dyslipidemia [21], metabolic syndrome [22], restrictive lung disease [23], osteoporosis [24].”
Rajan, R., Cherian, K. E., Paul, T., Asha, H. S., Jose, A., Rebekah, G. J., Thomas, N., & Kapoor, N. (2026) · Aging Medicine · doi:10.1002/agm2.70120
Metadata
- Authors
- Chung, J. H., Hwang, H. J., Shin, H.-Y., & Han, C. H.
- Affiliations
- Catholic Kwandong University International St. Mary's Hospital (KR)
- Seonam University (KR)
- National Health Insurance Service Ilsan Hospital (KR)
- Venue
- Annals of Nutrition and Metabolism
- Publisher
- S. Karger AG
- Published
- 2015-12-08
- Volume
- 68
- Issue
- 2
- Pages
- 77-84
- ISSN
- 0250-6807 (ISSN-L)
- 1421-9697
- OpenAlex
- W2193286004
- Cited by
- 78
- References
- 24
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 9 · 2023: 9 · 2022: 4 · 2021: 11 · 2020: 8 · 2019: 9 · 2018: 8 · 2017: 7 · 2016: 4
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Annals of Nutrition and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- sarcopenic obesity, osteosarcopenic obesity, bone mineral density, osteoporosis, sarcopenia, obesity, middle-aged and older adults, Korean population, prevalence, sex differences
- MeSH terms
- Aged, Aged, 80 and over, Bone Diseases, Metabolic, Female, Health Surveys, Humans, Life Style, Male, Middle Aged, Nutrition Surveys, Obesity, Osteoporosis, Sex Factors, Socioeconomic Factors, Absorptiometry, Photon, Bone Density, Prevalence, Sarcopenia, Republic of Korea
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.